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complexity (CCAD) in patients with ACS, with contrasting results.
Therefore, the aim of the current study was to evaluate the relationship between NLR, PLR, MPVLR, MPVPR, and CCAD in patients with ACS, using SS I algorithm.
MaterIals and Methods

Study population
This study is a retrospective study based on medical record review. Between February 2014 and June 2017, 599 acute coronary disease patients who met all the inclusion criteria were admitted to our university hospital. None of the exclusion criteria were included in the study. Our study was in compliance with the Declaration of Helsinki, and it was approved by our university Local Research Ethics Committee.
ACS was diagnosed according to the criteria recommended by the 2015 ECS guidelines. [22] The study population composed of patients with USAP, non-STEMI, and STEMI. Diagnosis of USAP was based on the chest pain suggesting USAP with or without ischemic electrocardiographic findings. The diagnosis of non-STEMI was made when characteristic angina pectoris lasted longer than 20 min with/without associated ST-segment depression of ≥0.1 mV and/or T-wave inversion in two contiguous leads in the electrocardiogram and presence of increased troponin T level over the diagnostic cutoff value. STEMI was diagnosed in the presence of angina pectoris lasting more than 20 min that associated with ST-segment elevation of ≥1 mm in at least two contiguous limb leads or ≥2 mm in at least two contiguous chest leads.
Exclusion criteria consisted of patients with a history of trauma, surgery, malignancy, infectious diseases within 30 days before admission, hematologic disorders, rheumatologic diseases (systemic lupus erythematosus, rheumatoid arthritis, and Kawasaki disease), severe chronic or acute renal disease, hepatic failure, use of immunosuppressive agents within 3 weeks before study entry. Individuals with prior percutaneous or surgical revascularization were excluded from the study as SS had been validated only for patients with native CAD.
Study protocol
Demographic characteristics and venous blood samples parameters were recorded form the patient's file. All subjects were evaluated with complete blood count (CBC), routine biochemical examination and ECG. The CBC parameters such as white blood count (WBC), hemoglobin (Hb), platelet count (PC), MPV, neutrophil, and lymphocyte were analyzed. The NLR, PLR, MPVLR, and MPVPR were calculated by dividing the absolute neutrophil count (NC) to the absolute lymphocyte count (LC), the absolute PC to absolute LC, MPV to the absolute LC, and MPV to the absolute PC, respectively. Fasting biochemical parameters such as the total cholesterol (TC), high-density lipoprotein, low-density lipoprotein (LDL), triglyceride (TG), and glucose levels were tested 1 day after hospital admission.
Coronary angiography and SYNTAX score I
Coronary angiography was performed by standard Judkins techniques through femoral approach. An invasive cardiologist evaluated the angiographic CD records using the SS system. Patients' CCAD score was calculated using an online calculator (http://www.syntaxscore.com/calculator/start.htm). Patients were divided into three groups according to their SS: low SS group (SSG) (≤22), intermediate SSG, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and high SSG (≥33). [23] 
Statistical analysis
Data were tested for normal distribution and variance homogeneity using Levene's test. Categorical variables were expressed as absolute frequencies and percentages while continuous parametric variables were expressed as the mean and standard deviation, and continuous nonparametric variables were expressed as the median value and 25 th -75 th percentile. One-way ANOVA test was used to compare the continuous variables with parametric distribution. Kruskal-Wallis H-test was utilized to compare continuous variables with nonparametric distribution. Categorical variables were assessed by Chi-square test. Pearson correlation test was applied in the correlation analysis. Receiver operating characteristics (ROC) curve analysis was used for PLR and MPVLR. All statistical analyzes were performed by SPSS 23 (SPSS, Inc., Chicago, Illinois, USA). P < 0.05 was considered statistically significant.
results
We conducted this single-center, medical record study through data retrieved between February 2014 and March 2018 at the cardiology department of the university hospital. A total of 599 (401 [66.9%] males and 198 [33.1%] females) patients with ACS were included in the study (P < 0.001). Patients were stratified into three groups according to their SS: low-SSG (n = 436, 72.8%, mean age: 61.26 ± 11.21), intermediate-SSG (n = 127, 21.2%, mean age: 66.65 ± 8.8), and high-SSG (n = 36.6%, mean age: 73.47 ± 8.6).
Demographic and clinical characteristics of these three groups are presented in Table 1 . The mean patient age was significantly higher in the high-SSG group than that in the low-and in-SSGs (P < 0.001). There was a significant difference in the number of male patients between the three groups (P = 0.01). The prevalence of diabetes mellitus and hypertension differed significantly between these three groups (P < 0.001 and P < 0.001, respectively). The mean of MCV, RDW, TC were significantly lower in the high-SSG group than that in the low-and in-SSG groups (P = 0.015, P = 0.028, P = 0.01). Urea and uric acid were significantly higher in the high-SSG group than that in the low-and in-SSG groups. The median of left ventricle ejection fraction and B-type natriuretic peptide were significantly lower in the high-SSG group than those in the low-and in-SSG groups (P < 0.001 and P = 0.004, respectively). However, the groups did not differ significantly with respect to body mass index; mean of SBP, diastolic blood pressure, pulse pressure, LDL, and TG.
The inflammatory markers, ratio of inflammatory markers, MPVLR, MPVPR, and CRP of the ACS patients according to the SS are presented in Table 2 . WBC, NC, LC, and NLR did not differ statistically between the three groups.
Although PC, MPV, and MPVPR did not differ significantly between these three groups. PLR and MPVLR were higher significantly in high-SSG group than those in the low-SSG and intermediate-SSG groups (P = 0.007 and P = 0.029, respectively).
The high-SSG group had higher CRP levels (1.5 ± 2.26 mg/dl) than the intermediate-SSG group (1.22 ± 1.57 mg/dl), and the intermediate-SSG group had higher CRP levels than the low SSG (1.14 ± 2.5 mg/dl) (P < 0.001).
Correlation analysis was performed to investigate the relationship between the SS and parameters (NLR, PLR, MPV, MPVLR, and MPVPR). A significant correlation was found between MPV, PLR, MPVLR, and SS (r = 0.094, P = 0.019; r = 0.095, P = 0.018 and r = 0.112, P = 0.005, respectively) [ Table 3 , Figures 1 and 2 ].
Univariate regression analysis showed statistically significant but weak correlations between PLR, MPVLR and CCAD (β = 0.009 [95% confidence interval [CI]: 0.002-0.016], P = 0.018 and β = 0.267 [95% CI: 0.081-0.453], P = 0.005, respectively) [ Table 4 ]. In addition, we performed multivariate regression analysis for variables that showed significance in the univariate model. Multivariate regression analysis revealed that MPVLR was not an independent predictor of CCAD (odds ratio [OR]. 1.070 [95% CI: 0.918-1.065), P = 0.761), whereas PLR was a weak predictor for CCAD (OR: 1.003 [95% CI: 1.001-1.006], P = 0.021) [ Table 4 ]. In the ROC curves analysis, the (area under the curve [AUC] = 0.560, 95% CI: 0.508-0.612, P = 0.023), with optimal cutoff value of 127.65 (sensitivity: 56.2%, specificity: 51.6%) for predicting CCAD [ Table 5 and Figure 3 ].
dIscussIon
In this study, we only included patients with ACS (USAP, non-STEMI, and STEMI). This study was designed to Main findings of our study were as follows: (1) although there was no correlation between NLR, MPVLR, and CCAD in ACS patients, (2) there was a weak positive correlation between PLR, MPVLR, and CCAD, (3) Univariate and multivariate regression analysis showed that MPVLR was not an independent predictor of CCAD, whereas PLR was a weak independent predictor of CCAD, and (4) PLR had a low sensitivity (56.2%) and specificity (51.6%) to predict intermediate and high anatomic CAD complexity (SS >22).
Ample research has shown that inflammation plays an important role in atherosclerotic CAD. Inflammatory cells are important at every stage of atherosclerotic lesions, their effector molecules accelerate progression of the lesions, and activation of inflammation can elicit ACS. [24, 25] In recent years, NLR, PLR, MPVLR, and MPVPR, derivate indexes of CBC assays, have emerged as the new prognostic markers for various diseases such as cardiovascular disorders, malignant diseases, stroke subtypes, transient ischemic attack and pulmonary diseases including cystic fibrosis, chronic obstructive pulmonary disease, and acute pulmonary embolism. [26] [27] [28] In this area, the most popular issue has certainly been CAD. NLR and PLR have been shown to have a predictive value in the detection of CCAD in patients with stable CAD. [11, [29] [30] [31] Furthermore, they have been used in prediction of major adverse cardiovascular events (a new episode or a recurrence of myocardial infarction, UASP, development or worsening of heart failure, re-hospitalization, stroke, in hospital and long-term mortality), [31] prognostication of CAD and evaluation of stent thrombosis risk. [32] [33] [34] [35] [36] However, few studies have investigated the relationship between inflammatory cell ratios and CCAD in ACS patients, and findings of these studies were insufficient to predict CCAD.
Chen et al. [37] evaluated NLR in 2976 CAD patients and 571 healthy controls. CCAD was assessed using Gensini score. A cutoff value of 2.04 for NLR predicted severe CAD according to Gensini score. In that study, acute and chronic CAD were evaluated together; inflammatory response in chronic CAD was different from ACS; hence, the results of this study could not be generalized to ACS patients.
Another study performed by Soylu et al. [13] investigated the relationship between NLR and SS in patients with non-STEMI. Patients were divided into three groups according to their NLR (NLR <2.6, NLR = 2.6-4.5, and NLR >4.5). Patients with high-NLR had higher SS than those with intermediate and low-NLR. Moreover, high NLR values were strong predictors of the in-hospital mortality in non-STEMI patients. Although they found a positive correlation between NLR and SS (r = 0.253 P = 0.001), independent predictive value of NLR for high SS was not investigated. The presence of correlation between NLR and SS did not mean that high NLR had a predictive value for CCAD.
Kurtul et al. [38] assessed the relationship between MPV, PLR and severity of CAD in patients with non-STEMI by using SS. NLR was found to be an independent predictor of severe atherosclerosis (coefficient β = 0.380, 95% CI: 1.165-1.917, P < 0.001), whereas MPV did not have such a predictive value (coefficient β = 1.010, 95% CI: 0.774-1.318, P = 0.941).
Kurtul A et al. [12] divided the 1016 non-STEMI patients into two groups: group 1 composed of patients with low SS (SS <22), group 2 composed of patients with intermediate and high SS.
They found a statistically significant difference with respect to PLR between the two groups, and a positive correlation was observed between PLR and SS (P < 0,001). Increased PLR was an independent predictor for high SS in non-STEMI patients (OR = 1.018, 95% CI: 1.013-1.023, P < 0.001). Moreover, in-hospital mortality was higher in group 2 than that in group 1 (OR = 1.004, 95% CI: 1.001-1.008, P = 0.032).
In our study, except for a weak positive correlation between PLR and CCAD, no correlation was observed with any of the parameters measured. According to both univariate and multivariate analysis results, PLR was a weak predictor of CCAD in ACS patients. The ROC analysis results confirmed the limited predictive value of PLR for CCAD in patients with ACS. Our findings contradicted the previous studies, [13, 37, 38] except for the study by Kurtul et al. [12] which was partially in concordance with our results.
Recent research has shown that inflammation is an integral part of atherosclerotic CAD. The degree of inflammatory activity depends on the characteristics of the atherosclerotic lesion. [2] Plaque analysis has demonstrated less local and systemic inflammatory activity in silent atherosclerotic (noncomplicated and nonvulnerable) plaque than complicated plaque. [39] It has been shown that ACS patients have higher levels of inflammatory cells and mediators including T-cell, CRP, interleukin-6, fibrinogen, interleukin-7, interleukin-8, soluble CD40 ligand, and C-reactive protein-related protein pentraxin-3 compared to patients with stable CAD, both systemically and within the lesion, suggesting the role of these mediators in atherosclerotic plaque rupture. [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] High levels of inflammatory mediators were associated with increased cardiovascular mortality and adverse cardiovascular events. [45] [46] [47] Increased levels of these mediators did not result from CCAD; rather they resulted from inflammatory response that was triggered by plaque rupture. [42] [43] [44] [45] [46] In the light of these data, it could be concluded that the presence of stable, non-complicated CAD was associated with both systemic and local low-grade inflammation. However, clinical forms of ACS were associated with high-grade inflammation, both systemically and locally. Overall, the existence of noncorrelation between NLR, PLR, MPVLR, MPVLR and CCAD was an expected result. Stable CAD patients with low-grade inflammatory activity might have higher CCAD; ACS patients with high-grade inflammatory activity might have lower CCAD, and vice versa. As the degree of inflammatory response depended on plaque complication (vulnerability, erosion, and rupture) in both patient groups, the circulating levels of inflammatory markers would differ between them.
Study limitations
The present study had several limitations. First, our study was retrospective, cross-sectional, and was based on patient file data. However, our study population consisted of a sufficient number of patients with ACS. Second, NLR PLR, MPVLR, and MPVPR were analyzed from the first blood samples at hospital admission rather than several samples at different time intervals. Third, these ratios were considerably affected by many factors, including dehydration, overhydration, diluted blood specimens, and in vitro blood specimen handling. Finally, the results of this study could be generalized for all ACS but not for USAP, non-STEMI, or STEMI. Therefore, a separate study was needed to evaluate the relationship between inflammatory markers and CCAD for each subgroup of patients.
conclusIon
ACS was almost always associated with rupture of an atherosclerotic plaque and outburst of systemic markers of inflammation. Since, patients with ACS might have both less complex CAD morphology and high levels of inflammatory response; they might have no correlation between them. Therefore, NLR, PLR, MPVLR, MPVPR could not be used for prediction of CCAD in patients with ACS.
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